RebrAIn expands capabilities with second FDA 510(k) clearance for OptimMRI software
RebrAIn, a France-based precision neurosurgery platform, has achieved a significant milestone with its second FDA 510(k) clearance for the OptimMRI software, marking a notable advancement in targeting techniques for both Deep Brain Stimulation (DBS) and lesioning procedures. RebrAIn’s latest FDA 510(k) clearance expands the capabilities of its OptimMRI software to include a new machine learning […]